Nano-X Imaging (NNOX) Total Non-Current Liabilities (2019 - 2026)

Nano-X Imaging (NNOX) posted quarterly Total Non-Current Liabilities of $5.3 million for Q1 2026, down 20.72% year-on-year from $6.7 million in Q1 2025, and down 3.61% on a QoQ basis from $5.5 million in Q4 2025.

Nano-X Imaging (NNOX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Nano-X Imaging (NNOX) has reported Total Non-Current Liabilities for 8 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 20.72% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (down 20.72% YoY) and the FY2025 annual result came in at $5.5 million, down 19.77% from the prior year.
  • Total Non-Current Liabilities fell to $5.3 million in Q1 2026 per NNOX's latest filing, from $5.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for NNOX reached as high as $19.2 billion in Q1 2022 and fell as low as $5.3 million in Q1 2026.
  • A 5-year average of $2.8 billion and a median of $7.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 1931150.0% — and 2023, when it sank 99.96%.
  • Year by year, Total Non-Current Liabilities stood at $12.2 million in 2022, then tumbled by 37.52% to $7.6 million in 2023, then dropped by 9.19% to $6.9 million in 2024, then declined by 19.77% to $5.5 million in 2025, then fell by 3.61% to $5.3 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $5.3 million, $5.5 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Nano-X Imaging 67.53 Mn 23.68 Mn -2.59 Mn 5.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.35 Mn
Dec 31, 2025 5.55 Mn
Sep 30, 2025 6.99 Mn
Jun 30, 2025 6.96 Mn
Mar 31, 2025 6.74 Mn
Dec 31, 2024 6.91 Mn
Sep 30, 2024 7.03 Mn
Jun 30, 2024 7.09 Mn
Mar 31, 2024 7.31 Mn
Dec 31, 2023 7.61 Mn
Sep 30, 2023 9.24 Mn
Jun 30, 2023 7.92 Mn
Mar 31, 2023 8.07 Mn
Dec 31, 2022 12.18 Mn
Sep 30, 2022 14.26 Bn
Jun 30, 2022 14.84 Bn
Mar 31, 2022 19.16 Bn
Dec 31, 2021 18.27 Mn
Sep 30, 2021 3.71 Mn
Jun 30, 2021 868,000.00